Invention Grant
US09314522B2 Antitumors combinations containing antibodies recognizing specifically CD38 and bortezomib
有权
含有特异性识别CD38和硼替佐米的抗体的抗肿瘤组合
- Patent Title: Antitumors combinations containing antibodies recognizing specifically CD38 and bortezomib
- Patent Title (中): 含有特异性识别CD38和硼替佐米的抗体的抗肿瘤组合
-
Application No.: US13992684Application Date: 2011-12-08
-
Publication No.: US09314522B2Publication Date: 2016-04-19
- Inventor: Jutta Deckert , Pascale Lejeune , Michele Mayo , Peter U. Park
- Applicant: Jutta Deckert , Pascale Lejeune , Michele Mayo , Peter U. Park
- Applicant Address: FR Paris
- Assignee: Sanofi
- Current Assignee: Sanofi
- Current Assignee Address: FR Paris
- Agency: Lathrop & Gage LLP
- Agent James H. Velema, Esq.
- Priority: EP10306395 20101210
- International Application: PCT/EP2011/072228 WO 20111208
- International Announcement: WO2012/076663 WO 20120614
- Main IPC: A61K39/395
- IPC: A61K39/395 ; A61K38/05 ; C07K16/28
Abstract:
Pharmaceutical composition comprising an antibody specifically recognizing CD38 and bortezomib.
Public/Granted literature
- US20140186337A1 Antitumors Combinations Containing Antibodies Recognizing Specifically CD38 And Bortezomib Public/Granted day:2014-07-03
Information query
